Involvement of accumulated NOS inhibitors and endothelin-1, enhanced arginase, and impaired DDAH activities in pulmonary dysfunction following subarachnoid hemorrhage in the rabbit

Vascular Pharmacology

Volumn 48, Issue 1, 2008, Pages 21-31

  Mizuno, Yusuke ^a   Isotani, Eiji ^a   Ohno, Kikuo ^a   Nagai, Akiko ^b   Imamura, Masatoshi ^b   Azuma, Hiroshi ^b  

^a Tokyo Medical and Dental University   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Arginase; DDAH; Endogenous NOS inhibitors; Experimental SAH; Pulmonary dysfunction

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; AMINOGUANIDINE; ARGINASE; ARGININE; CYCLIC GMP; DIMETHYLARGININASE; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; ENZYME INHIBITOR; HYDROLASE; INDOMETACIN; ISOBUTYLMETHYLXANTHINE; LEUPEPTIN; MONOMETHYLARGININE; N(G) NITROARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; BLOOD VESSEL WALL; CISTERNA MAGNA; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL STUDY; LUNG DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RABBIT; SUBARACHNOID HEMORRHAGE;

ACETYLCHOLINE; AMIDOHYDROLASES; ANIMALS; ARGINASE; CYCLIC GMP; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; INDOMETHACIN; LUNG DISEASES; MALE; MODELS, BIOLOGICAL; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; OXADIAZOLES; PULMONARY ARTERY; QUINOXALINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

EID: 38349006514     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.11.002     Document Type: Article

References (48)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthase: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
2. Azuma H., Hamasaki H., Niimi Y., Terada T., and Matsubara O. Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. Am. J. Physiol. 267 (1994) H2259-H2267
3. Azuma H., Sato J., Hamasaki H., Sugimoto A., Isotani E., and Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of l-arginine in regenerated endothelial cells. Br. J. Pharmacol. 115 (1995) 1001-1004
4. Azuma H., Masuda H., Sato J., Niwa K., and Tokoro T. A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle. Exp. Eye Res. 64 (1997) 823-830
5. Beppu M., Obayashi S., Aso T., Goto M., and Azuma H. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall and intimal hyperplasia in perimenopausal human uterine arteries. J. Cardiovasc. Pharmacol. 39 (2002) 192-200
6. Bode-Böger S.M., Böger R.H., Kienke S., Junker W., and Frölich J.C. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun. 219 (1996) 589-603
7. Böger R.H., Bode-Böger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., and Cooke J.P. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
8. G-monomethylarginine-l-arginine uptake: a mechanism for differential inhibition of NO synthases?. Am. J. Physiol. 269 (1995) C750-C756
9. Boulanger C., and Lüscher T.F. Release of endothelin from the porcine aorta, inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990) 587-590
10. G-hydroxy-l-arginine during high-output NO production. Am. J. Physiol. 271 (1996) H1988-H1998
11. Chen Y.F., and Oparil S. Endothelin and pulmonary hypertension. J. Cardiovasc. Pharmacol. 35 4 Suppl 2 (2000) S49-S53
12. Chinkers M., and Garbers D.L. Signal transduction by guanylyl cyclase. Ann. Rev. Biochem. 60 (1991) 553-575
13. Deehan S.C., and Grant I.S. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intense Care Med. 22 (1996) 672-676
14. Di Pasquale G., Andreoli A., Lusa A.M., Urbinati S., Biancoli S., Cere E., Borgatti M.L., and Pinelli G. Cardiologic complications of subarachnoid hemorrhage. J. Neurosurg. Sci. 42 (1998) 33-36
15. Elrifai A.M., Bailes J.E., Shih S.R., Dianzumba S., and Brillman J. Characterization of the cardiac effects of acute subarachnoid hemorrhage in dogs. Stroke 27 (1996) 737-741
16. Fard A., Tuck C.H., Donis J.A., Sciacca R., Di, Tullio M.R., Wu H.D., Bryant T.A., Chen N.T., Torres-Tamayo M., Ramasamy R., Berglund L., Ginsberg H.N., Homma S., and Cannon P.J. Acute elevation of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2039-2044
17. Goto M., Yamauchi Y., Kurosaki E., and Azuma H. Possible involvement of facilitated polyol pathway in augmentation of intimal hyperplasia in rabbits with alloxan-induced hyperglycemia. J. Cardiovasc. Pharmacol. 41 (2003) 265-275
18. Hamasaki H., Sato J., Masuda H., Tamaoki S., Isotani E., Obayashi S., Udagawa T., and Azuma H. Effect of nicotine on the intimal hyperplasia after endothelial removal of the rabbit carotid artery. Gen. Pharmacol. 28 (1997) 653-659
19. Hirata Y., Takagi Y., Fukuda Y., and Marumo F. Endothelin is a potent mitogen for rat smooth muscle cells. Arteriosclerosis 78 (1989) 225-228
20. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 535-560
21. Ignarro L.J. Nitric oxide. A novel signal transduction mechanism for intracellular communication. Hypertension 16 (1990) 477-483
22. Ignarro L.J., Buga G.M., Wei L.-H., Bauer P.M., and Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. 98 (2001) 4202-4208
23. Ishizaka K., Azuma H., Matsubara O., Kitahara S., and Oshima H. Production of endothelin by canine prostatic epithelial cells and its stimulatory effect on their growth. J. Androl. 20 (1999) 529-536
24. Isotani E., Suzuki R., Tomita K., Hokari M., Monma S., and Hirakawa K. Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke 25 (1994) 2198-2203
25. Isotani E., Azuma H., Suzuki R., Hamasaki H., Sato J., and Hirakawa K. Impaired endothelium-dependent relaxation in rabbit pulmonary artery after subarachnoid hemorrhage. J. Cardiovasc. Pharmacol. 28 (1996) 639-644
26. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., and Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 1092-1095
27. Ito Y., Isotani E., Mizuno Y., Azuma H., and Hirakawa K. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin. J. Cardiovasc. Pharmacol. 35 (2000) 45-50
28. Kelly L.K., Wedgwood S., Steinhorn R.H., and Black S.M. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am. J. Physiol. 286 (2004) L984-L991
29. Kubota Y., Isotani E., Mizuno Y., Ohno K., and Azuma H. Alterations of intracellular calcium concentration and nitric oxide generation in pulmonary artery endothelium after subarachnoid hemorrhage of the rabbit. Vasc. Pharmaccol. 47 (2007) 90-98
30. Li H., Meininger C.J., Hawker Jr. J.R., Haynes T.E., Kepka-Lenhart D., Mistry S.K., Morris Jr. S.M., and Wu G. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am. J. Physiol. 280 (2001) E75-E82
31. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., and Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus, role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 (2002) 987-992
32. Loyaga-Rendon R.Y., Sakamoto S., Beppu M., Aso T., Ishizaka M., Takahashi R., and Azuma H. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. Atherosclerosis 178 (2005) 231-239
33. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russel R.J., Hodson H., Whitley G.S., and Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119 (1996) 1533-1540
34. Masuda H., Goto M., Tamaoki S., and Azuma H. Accelerated intimal hyperplasia and increased endogenous NOS inhibitors in rabbits with alloxan-induced hyperglycaemia. Br. J. Pharmacol. 126 (1999) 211-218
35. Masuda H., Tsujii T., Okuno T., Kihara K., Goto M., and Azuma H. Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischemia. Br. J. Pharmacol. 133 (2001) 97-107
36. Masuda H., Tsujii T., Okuno T., Kihara K., Goto M., and Azuma H. Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia. Am. J. Physiol. 282 (2002) R1730-R1738
37. Mori M., and Goto T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. 275 (2000) 715-719
38. Moro M., Russel R., Cellek S., Lizasoani I., Su Y., Darley-Usmer V., Radomski M., and Moncada S. CGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. 93 (1996) 1480-1485
39. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264 (1989) 10205-10209
40. Shishido T., Suzuki R., Qian L., and Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 25 (1994) 864-868
41. Stuhlinger M.C., Tsao P.S., Her J.-H., Kimoto M., Balint R.F., and Cooke J.P. Homocystein impairs the nitric oxide synthase pathway, role of asymmetric dimethylarginine. Circulation 104 (2001) 2569-2575
42. Surdacky A., Nowicki J.S., Sandman J., Tsikas D., Kruszelnicka-Lwiatkowska O., Kokot F., Dubiel J.S., and Froelich J.C. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 33 (1999) 652-658
43. Vallance P., Leone A.M., Calver A., Collier J., and Moncada S. Accumulation of and endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
44. Webb D.J., and Strachan F.E. Clinical experience with endothelin antagonists. Am. J. Hypertens. 11 (1998) 71S-79S
45. Wei L.H., Wu G., Morris Jr. S.M., and Ignarro L.J. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc. Natl. Acad. Sci. 98 (2001) 9260-9264
46. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998) 1-17
47. Yanagisawa M., Kurihara H., Kimura S., Tomobe M., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
48. Yoo J.-H., and Lee S.-C. Elevated plasma homocysteine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158 (2001) 425-430